Beijing Bozhiyin T&S Co., Ltd. Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Beijing China (2004)

Organization Overview

First Clinical Trial
2012
NCT01935453
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Beijing Bozhiyin T&S Co., Ltd.

Active Ingredients

Drugs in Phase 4 Trials (3)

danhong (2 trials)

sodium chloride (3 trials)

wen xin (1 trial)

Drugs in Phase 3 Trials (3)

Allantoin (1 trial)

metronidazole (flagyl) (1 trial)

urea (1 trial)

Drugs in Phase 1 Trials (2)

hgm-csf herpes simplex virus injection (1 trial)

rotigotine (neupro) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Premature Complexes (Phase 4)

Cardiac Complexes, Premature (Phase 4)

Herpes Simplex (Phase 1)

Ileus (Phase 3)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Parkinson Disease (Phase 1)

Premature Birth (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8